Karalicin, a new biologically active compound from Pseudomonas fluorescens/putida. II. Biological properties.
The biological activities of karalicin, a new product from the Pseudomonas fluorescens/putida strain SS-3 (CCM 4430) are described. It shows a weak, but specific and irreversible, antiviral activity on Herpes simplex viruses. It also presents some inhibitory activity on different species of yeasts.
Lampis
G
G
Cattedra di Microbiologia Applicata, Universita di Cagliari, Italy.
Deidda
D
D
Maullu
C
C
Petruzzelli
S
S
Pompei
R
R
Monache
F D
FD
Satta
G
G
D000818:Animals; D000840:Anisoles / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D000935:Antifungal Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D000998:Antiviral Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects; D016923:Cell Death / Q000187:drug effects; D002460:Cell Line; D002522:Chlorocebus aethiops; D018259:Herpesvirus 1, Human / Q000187:drug effects / Q000254:growth & development; D018258:Herpesvirus 2, Human / Q000187:drug effects; D015394:Molecular Structure; D000439:Pentanols / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D017955:Poliovirus / Q000187:drug effects; D011551:Pseudomonas fluorescens / Q000378:metabolism; D016958:Pseudomonas putida / Q000378:metabolism; D014616:Vaccinia virus / Q000187:drug effects; D014709:Vero Cells; D015003:Yeasts / Q000187:drug effects
D000840:Anisoles; D000935:Antifungal Agents; D000998:Antiviral Agents; D000439:Pentanols; C099306:karalicin